🟢 LLY is trading 3% up today following Freedom Capital upgrade and Orna acquisition

LLY is trading at $1045.74 (+3.01%) today following a Freedom Capital upgrade to Buy and the company's $2.4B acquisition of Orna Therapeutics.

• Freedom Capital set a $1,200 price target, highlighting growth momentum from the Orna acquisition and the company's expanding pipeline.
• Eli Lilly is bucking a broader market decline, with the S&P 500 and Nasdaq both down over 1% during the open session.
• The stock continues to benefit from strong Q4 earnings reported on February 4, which featured robust GLP-1 drug sales and upbeat 2026 guidance.